The Lancet Diabetes & Endocrinology
banner
thelancetendo.bsky.social
The Lancet Diabetes & Endocrinology
@thelancetendo.bsky.social
Your leading source of international, cutting-edge research, review, and opinion in clinical #diabetes and #endocrinology. IF=41·8.

🌐 thelancet.com/journals/landia/home
Michael Roden comments on:
The long and winding road to precision diabetology thelancet.com/journals/lan... thelancet.com/journals/lan...
#diabetes #subgroups #PrecisionMedicine

#MedSky #EndoSky
November 15, 2025 at 7:54 AM
Also read the Linked Comment;
#Empagliflozin in chronic #kidney disease: evidence for early, inclusive, and confident use www.thelancet.com/journals/lan...
#CKD #T2D
#FREE to read with registration (also FREE)

#MedSky #endoSky #RenalSky
Empagliflozin in chronic kidney disease: evidence for early, inclusive, and confident use
The scenario of chronic kidney disease (CKD) management has been transformed by the advent of sodium glucose co-transporter-2 (SGLT2) inhibitors, a class of drugs with benefits extending well beyond g...
www.thelancet.com
November 12, 2025 at 7:58 PM
Dan Alexandru Niculescu comments on:
The road towards standardisation in cyclic Cushing's syndrome thelancet.com/journals/lan...
cyclic #Cushing's syndrome (#cCS)

#MedSky #EndoSky
The road towards standardisation in cyclic Cushing's syndrome
Endogenous Cushing's syndrome is a severe, potentially lethal, endocrine condition. It is well known for its pleomorphic clinical manifestations that often overlap with those of frequent endocrine and...
thelancet.com
November 10, 2025 at 7:22 PM